Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair of the Board.
From Calluna PharmaOct 14 2024 Calluna Pharma AS , a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the appointments of Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Chair of the Board. Alongside these appointments, John Montana, who has been acting as the Company's interim CEO, will return to his role as an Operating Partner at Forbion.
Gaffney brings over 20 years of experience in corporate strategy, business development, and operations in both private and public biotechnology companies, and will lead the team that defines and executes on the corporate strategy, particularly as its lead program is on pace to complete its Phase 1 program later this year.
Altmeyer, the newly appointed Independent Chair of the Calluna Board, brings extensive leadership experience, having served on the boards and as an advisor to several pharma and biotech companies. He is currently Chair of AM-Pharma and also serves on the boards of Novaremed, Merz Therapeutics, Aculys, and Alector, all focusing on CNS and neurological treatments.
It has been a rapid and impressive start to our journey as Calluna Pharma following joining forces of Oxitope Pharma and Arxx Therapeutics, two key players in the innate immunology space. I am delighted to join the team at such an exciting stage with Calluna’s lead candidate, CAL101, completing its Phase 1 program this year, and with the other programs in our pipeline demonstrating such promise.
Marco Boorsma, General Partner, Forbion, outgoing Chair and member of the Board of Calluna Pharma, added: “Calluna’s tailored approach to targeting the root causes of many diseases can be successful where other treatment strategies have fallen short. The Company and its pipeline are poised for success, and I feel confident as we hand over the Chairmanship to Mark Altmeyer who brings vast experience for the next phase of this journey.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pushing the limits — Pharma characterization with light scatteringBettersize's upcoming webinar will delve into particle size and zeta potential, showcasing their importance in pharmaceutical development and product quality.
Read more »
Alzheimer’s ‘wonder drug’ was approved by scientists funded by pharma firmA BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab received direct payments from drug companies
Read more »
East Kilbride Fairtrade Group mark 30 years in the townThe Fairtrade Fortnight event was well attended by local church members, members of the community and local councillors
Read more »
Mohamed al Fayed claims mark 'one of the worst cases of corporate sexual exploitation'Lawyers representing 37 alleged victims of the former Harrods owner branded the late billionaire 'a monster'.
Read more »
John Higgins hits 1,000th century in English Open defeat to Mark AllenJohn Higgins becomes the second player to hit 1,000 centuries on his way to a narrow 4-3 last-16 defeat to Mark Allen in the English Open.
Read more »
Trump-backed North Carolina Republican Mark Robinson denies calling himself 'black nazi' on pornographic forumLt Gov Mark Robinson, who Donald Trump has endorsed, is running to be the governor of North Carolina. A CNN report said he posted racial and sexual comments on a pornography website's message board more than a decade ago.
Read more »